Covered recipient · General Payments record
JAKALYN JANE GOSSETT
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$587.57
- Reported across 35 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $289.88 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $88.36 | 4 |
| Acerta Pharma LLC | $80.28 | 5 |
| Amgen Inc. | $55.64 | 4 |
| Lilly USA, LLC | $34.75 | 2 |
| Novo Nordisk AS | $30.85 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.12 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107240280 | CMS |
| ABBVIE INC. | $27.59 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107240282 | CMS |
| ABBVIE INC. | $19.74 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107240284 | CMS |
| ABBVIE INC. | $18.91 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107240286 | CMS |
| Amgen Inc. | $13.34 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117565812 | CMS |
| Amgen Inc. | $15.21 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117565814 | CMS |
| Amgen Inc. | $13.89 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117565816 | CMS |
| Amgen Inc. | $13.20 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117565818 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.52 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104302024 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.40 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105342293 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.75 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104515304 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.34 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104733287 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.27 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105488781 | CMS |
| Lilly USA, LLC | $16.50 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135688846 | CMS |
| Lilly USA, LLC | $18.25 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135686790 | CMS |
| Novo Nordisk Inc | $13.92 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100308925 | CMS |
| Novo Nordisk Inc | $16.93 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100333862 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.